Why the study?
The high mortality of acute myocardial infarction with cardiogenic shock remains challenging, and institutional factors independently associated with prognosis needed examination.
Does treatment at hospitals with a higher number of JCS board-certified members improve 30-day mortality in patients with Killip class IV AMI?
Does treatment at hospitals with a higher number of JCS board-certified members improve 30-day mortality in patients with Killip class IV AMI?
Treatment of AMI complicated by cardiogenic shock at hospitals with a higher number of board-certified cardiologists is associated with significantly lower 30-day mortality.
Supports higher cardiologist certification in shock AMI centers; leaves open causality and need for prospective confirmation.
BACKGROUND: The high mortality of acute myocardial infarction (AMI) with cardiogenic shock (i.e., Killip class IV AMI) remains a challenge in emergency cardiovascular care. This study aimed to examine institutional factors, including the number of JCS board-certified members, that are independently associated with the prognosis of Killip class IV AMI patients. METHODS AND RESULTS: In the Japanese registry of all cardiac and vascular diseases-diagnosis procedure combination (JROAD-DPC) database (years 2012-2016), the 30-day mortality of Killip class IV AMI patients (n=21,823) was 42.3%. Multivariate analysis identified age, female sex, admission by ambulance, deep coma, and cardiac arrest as patient factors that were independently associated with higher 30-day mortality, and the numbers of JCS board-certified members and of intra-aortic balloon pumping (IABP) cases per year as institutional factors that were independently associated with lower mortality in Killip class IV patients, although IABP was associated with higher mortality in Killip classes I-III patients. Among hospitals with the highest quartile (≥9 JCS board-certified members), the 30-day mortality of Killip class IV patients was 37.4%. CONCLUSIONS: A higher numbers of JCS board-certified members was associated with better survival of Killip class IV AMI patients. This finding may provide a clue to optimizing local emergency medical services for better management of AMI patients in Japan.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied this question.